What drugs does SALERNO PHARMS make?

SALERNO PHARMS has 1 FDA-approved drugs including FLOLIPID.

What therapeutic areas does SALERNO PHARMS focus on?

SALERNO PHARMS focuses primarily on Cardiovascular and Metabolic.

← Back

Data updated: Mar 10, 2026

SALERNO PHARMS

CardiovascularMetabolic

Pharma

SALERNO PHARMS is a pharmaceutical company focused on Cardiovascular, Metabolic. Key products include FLOLIPID.

2016

Since

Drugs

Trials

Approved (2yr)

Key Drugs

FLOLIPID

simvastatin

Cardiovascular

HMG-CoA reductase 9 indications · 2016

Recent Activity

No recent activity

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 50%

1 drugs

Metabolic 50%

1 drugs

Pipeline Strength ProEarly access

Competitors ProEarly access

Merck big-pharma

Cardiovascular, Metabolic

Johnson & Johnson big-pharma

Cardiovascular, Metabolic

Bayer big-pharma

Cardiovascular, Metabolic

B BRAUN specialty

Metabolic, Cardiovascular

AstraZeneca big-pharma

Cardiovascular, Metabolic

SALERNO PHARMS

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (1)

Active (1)

Discontinued (0)

Company Info